ÂÜÀòÂÒÂ×

Elicio Therapeutics

1 follower

‌

Elicio is committed to transforming the lives of patients and their families by re-engineering the body’s immune response to cancer.

Industries

Employees

11-50

Links

Org chart

Robert Connelly

Collapse
Peter C. DeMuth
Chief Scientific Officer
Christopher Haqq
EVP, Head of R&D & CMO
Esther Welkowsky
SVP, Clinical Development
Joy Seymour
VP & Head of Regulatory Affairs
Steve Flores
VP, Supply Chain
Michael Divecchia
SVP, Operations & Human Resources